Arlene Smaldone1, Sally Findley2, Deepa Manwani3, Haomiao Jia4, Nancy S Green5. 1. Columbia University School of Nursing, New York, NY; College of Dental Medicine, Columbia University Medical Center, New York, NY. Electronic address: ams130@columbia.edu. 2. Mailman School of Public Health, Columbia University, New York, NY. 3. Department of Pediatrics, Albert Einstein College of Medicine, New York, NY. 4. Columbia University School of Nursing, New York, NY; Mailman School of Public Health, Columbia University, New York, NY. 5. Department of Pediatrics, Columbia University Medical Center, New York, NY.
Abstract
OBJECTIVES: To examine the effect of a community health worker (CHW) intervention, augmented by tailored text messages, on adherence to hydroxyurea therapy in youths with sickle cell disease, as well as on generic and disease-specific health-related quality of life (HrQL) and youth-parent self-management responsibility concordance. STUDY DESIGN: We conducted a 2-site randomized controlled feasibility study (Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment [HABIT]) with 2:1 intervention allocation. Youths and parents participated as dyads. Intervention dyads received CHW visits and text message reminders. Data were analyzed using descriptive statistics, the Wilcoxon signed-rank test, and growth models adjusting for group assignment, time, and multiple comparisons. Changes in outcomes from 0 to 6 months were compared with their respective minimal clinically important differences. RESULTS: A total of 28 dyads (mean age of youths, 14.3 ± 2.6 years; 50% Hispanic) participated (18 in the intervention group, 10 in the control group), with 10.7% attrition. Accounting for group assignment, time, and multiple comparisons, at 6 months intervention youths reported improved generic HrQL total score (9.8 points; 95% CI, 0.4-19.2) and Emotions subscale score (15.0 points; 95% CI, 1.6-28.4); improved disease-specific subscale scores for Worry I (30.0 points; 95% CI, 8.5-51.5), Emotions (37.0 points, 95% CI, 9.4-64.5), and Communication I (17.8 points; 95% CI, 0.5-35.1); and 3-month dyad self-management responsibility concordance (3.5 points; 95% CI, -0.2 to 7.1). There were no differences in parent proxy-reported HrQL measures at 6 months. CONCLUSIONS: These findings add to research examining effects of behavioral interventions on HrQL outcomes in youths with sickle cell disease. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02029742.
RCT Entities:
OBJECTIVES: To examine the effect of a community health worker (CHW) intervention, augmented by tailored text messages, on adherence to hydroxyurea therapy in youths with sickle cell disease, as well as on generic and disease-specific health-related quality of life (HrQL) and youth-parent self-management responsibility concordance. STUDY DESIGN: We conducted a 2-site randomized controlled feasibility study (Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment [HABIT]) with 2:1 intervention allocation. Youths and parents participated as dyads. Intervention dyads received CHW visits and text message reminders. Data were analyzed using descriptive statistics, the Wilcoxon signed-rank test, and growth models adjusting for group assignment, time, and multiple comparisons. Changes in outcomes from 0 to 6 months were compared with their respective minimal clinically important differences. RESULTS: A total of 28 dyads (mean age of youths, 14.3 ± 2.6 years; 50% Hispanic) participated (18 in the intervention group, 10 in the control group), with 10.7% attrition. Accounting for group assignment, time, and multiple comparisons, at 6 months intervention youths reported improved generic HrQL total score (9.8 points; 95% CI, 0.4-19.2) and Emotions subscale score (15.0 points; 95% CI, 1.6-28.4); improved disease-specific subscale scores for Worry I (30.0 points; 95% CI, 8.5-51.5), Emotions (37.0 points, 95% CI, 9.4-64.5), and Communication I (17.8 points; 95% CI, 0.5-35.1); and 3-month dyad self-management responsibility concordance (3.5 points; 95% CI, -0.2 to 7.1). There were no differences in parent proxy-reported HrQL measures at 6 months. CONCLUSIONS: These findings add to research examining effects of behavioral interventions on HrQL outcomes in youths with sickle cell disease. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02029742.
Authors: Lewis L Hsu; Nancy S Green; E Donnell Ivy; Cindy E Neunert; Arlene Smaldone; Shirley Johnson; Sheila Castillo; Amparo Castillo; Trevor Thompson; Kisha Hampton; John J Strouse; Rosalyn Stewart; TaLana Hughes; Sonja Banks; Kim Smith-Whitley; Allison King; Mary Brown; Kwaku Ohene-Frempong; Wally R Smith; Molly Martin Journal: Am J Prev Med Date: 2016-07 Impact factor: 5.043
Authors: Marc S Zumberg; Suresh Reddy; Robert L Boyette; Robert J Schwartz; Thomas R Konrad; Richard Lottenberg Journal: Am J Hematol Date: 2005-06 Impact factor: 10.047
Authors: Brian H Wrotniak; Joan I Schall; Megan E Brault; Dorene F Balmer; Virginia A Stallings Journal: J Pediatr Health Care Date: 2012-11-08 Impact factor: 1.812
Authors: David C Brousseau; J Paul Scott; Oluwakemi Badaki-Makun; Deepika S Darbari; Corrie E Chumpitazi; Gladstone E Airewele; Angela M Ellison; Kim Smith-Whitley; Prashant Mahajan; Sharada A Sarnaik; T Charles Casper; Lawrence J Cook; J Michael Dean; Julie Leonard; Monica L Hulbert; Elizabeth C Powell; Robert I Liem; Robert Hickey; Lakshmanan Krishnamurti; Cheryl A Hillery; Mark Nimmer; Julie A Panepinto Journal: Blood Date: 2015-07-31 Impact factor: 22.113